Science. 2008 May 9;320(5877):760-4.

Toward an AIDS vaccine.

Source

Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA. bwalker@partners.org

Abstract

A quarter century of scientific discovery has been applied to developing an AIDS vaccine, yet this goal remains elusive. Specific characteristics of the virus, including the extreme genetic variability in circulating viral isolates worldwide, biological properties of HIV that impede immune attack, and a high mutation rate that allows for rapid escape from adaptive immune responses, render this a huge challenge. However, evidence of protection against AIDS viruses in animal models and control of HIV in humans under certain circumstances, together with scientific advances in understanding disease pathogenesis, provide a strong rationale and objective paths to continue the pursuit of an effective AIDS vaccine to stem the global epidemic.

PMID:: 18467582; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Absence of the Testes, Congenital or Acquired - Genetic Alliance

Supplemental Content

Save items

Related citations in PubMed

Review [Theory for prophylactic AIDS vaccine development]. [Uirusu. 2009]
Review [Theory for prophylactic AIDS vaccine development].
Nomura T, Matano T. Uirusu. 2009 Dec; 59(2):267-75.
25 years of HIV research! ... and what about a vaccine? [Eur J Immunol. 2009]
25 years of HIV research! ... and what about a vaccine?
Appay V. Eur J Immunol. 2009 Aug; 39(8):1999-2003.
Review Progress toward an HIV vaccine. [Annu Rev Med. 2005]
Review Progress toward an HIV vaccine.
Letvin NL. Annu Rev Med. 2005; 56:213-23.
Immunology and the elusive AIDS vaccine. [Nature. 2010]
Immunology and the elusive AIDS vaccine.
Virgin HW, Walker BD. Nature. 2010 Mar 11; 464(7286):224-31.
Review Clinical trials of HIV vaccines. [Annu Rev Med. 2002]
Review Clinical trials of HIV vaccines.
Graham BS. Annu Rev Med. 2002; 53:207-21.

See reviews... See all...

Cited by 90 PubMed Central articles

Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic properties. [BMC Biophys. 2012]
Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic properties.
López de Victoria A, Kieslich CA, Rizos AK, Krambovitis E, Morikis D. BMC Biophys. 2012 Feb 7; 5:3. Epub 2012 Feb 7.
Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. [PLoS One. 2012]
Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein.
Dey AK, Burke B, Sun Y, Sirokman K, Nandi A, Hartog K, Lian Y, Geonnotti AR, Montefiori D, Franti M, et al. PLoS One. 2012; 7(1):e30233. Epub 2012 Jan 24.
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand. [PLoS One. 2011]
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.
Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, et al. PLoS One. 2011; 6(12):e27837. Epub 2011 Dec 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Toward an AIDS vaccine.
Toward an AIDS vaccine.
Science. 2008 May 9 ;320(5877):760-4.

PubMed
An in vivo map of the yeast protein interactome.
An in vivo map of the yeast protein interactome.
Science. 2008 Jun 13 ;320(5882):1465-70. Epub 2008 May 8 .

PubMed
Spatial approximation between secretin residue five and the third extracellular ...
Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
Mol Pharmacol. 2008 Aug ;74(2):413-22. Epub 2008 May 8 .

PubMed
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignan...
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
Ann Rheum Dis. 2009 May ;68(5):648-53. Epub 2008 May 8 .

PubMed
Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in ...
Cytosol-nucleus traffic and colocalization with FXR of conjugated bile acids in rat hepatocytes.
Am J Physiol Gastrointest Liver Physiol. 2008 Jul ;295(1):G54-G62. Epub 2008 May 8 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Toward an AIDS vaccine.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 90 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information